I'm not arguing the viabilty of a T-cig. My point is whether RFMK really/currently has what it takes to execute.
Think about it: RFMK, consultants on DTCC matters, gets womped by the DTCC. They lose credit rating (not to mention competency confidence) and ability to raise funds because of this. This is a publicly traded company relying solely on raising funds publicly. Gen 1 is admittedly inferior to Gen 2, if they even get it right the second time around. RFMK stated they had sufficient capital to see them thru Gen 1 with revenues carrying themselves forward. BUT, Gen 1 isn't viable, or else the MASSIVE market woulda signed a contract in a heartbeat. It got laughed at though. Hence the need for a Gen 2.
So, we have RFMK spending their available funds on Gen 1, a non-viable product. Publicly traded Gen 2 needs to be produced. Who's gonna pay for it?
IHub's Most Marked Board: investorshub.advfn.com/boards/board.aspx?board_id=7489
